DANIEL L. KISNER - 26 May 2022 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
Director
Signature
Daniel L. Kisner, M.D., by /s/ Trevor Dutcher, Attorney-in-Fact
Issuer symbol
DVAX
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 17:00:55 UTC
Previous filing
03 Sep 2021
Next filing
03 Jun 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Award +5,357 5,357 26 May 2022 Common Stock 5,357 Direct F1
transaction DVAX Option (Right to Buy) Award +22,500 22,500 26 May 2022 Common Stock 22,500 $11.68 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company.
F2 This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.
F3 Not applicable.